{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:48:18Z","timestamp":1790354898439,"version":"4.1.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00527","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T04:22:00Z","timestamp":1596514920000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center"],"prefix":"10.3389","volume":"11","author":[{"given":"Aram","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo-Sik","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Kyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"g5390","DOI":"10.1136\/bmj.g5390","article-title":"Diagnosis and management of prolactinomas and non-functioning pituitary adenomas","volume":"349","author":"Rogers","year":"2014","journal-title":"BMJ."},{"key":"B2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000236081","article-title":"Prolactinoma in children and adolescents","volume":"72","author":"Fideleff","year":"2009","journal-title":"Horm Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/17446651.2017.1306439","article-title":"Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening","volume":"12","author":"Iacovazzo","year":"2017","journal-title":"Expert Rev Endocrinol Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1210\/jcem-71-6-1427","article-title":"Clonal origin of pituitary adenomas","volume":"71","author":"Herman","year":"1990","journal-title":"J Clin Endocrinol Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary."},{"key":"B8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00431-017-3042-5","article-title":"Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis","volume":"177","author":"Hoffmann","year":"2018","journal-title":"Eur J Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/qjmed\/hcs240","article-title":"Macroprolactinoma: a diagnostic and therapeutic update","volume":"106","author":"Iglesias","year":"2013","journal-title":"QJM."},{"key":"B10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11102-008-0149-8","article-title":"Clinical profile and long term follow up of children and adolescents with prolactinomas","volume":"12","author":"Acharya","year":"2009","journal-title":"Pituitary."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/jcem.83.8.5001","article-title":"Prolactinomas in children and adolescents. clinical presentation and long-term follow-up","volume":"83","author":"Colao","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ecl.2007.10.013","article-title":"Hyperprolactinemia and prolactinomas","volume":"37","author":"Mancini","year":"2008","journal-title":"Endocrinol Metab Clin North Am."},{"key":"B13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000262536","article-title":"Prolactinomas in children and adolescents","volume":"17","author":"Colao","year":"2010","journal-title":"Endocr Dev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","article-title":"Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients","volume":"158","author":"Kreutzer","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-016-0766-6","article-title":"Significance of surgical management for cystic prolactinoma","volume":"20","author":"Ogiwara","year":"2017","journal-title":"Pituitary."},{"key":"B16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.2000.93.supplement_3.0014","article-title":"Gamma knife radiosurgery for prolactinomas","volume":"93","author":"Landolt","year":"2000","journal-title":"J Neurosurg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/jns.2002.97.supplement_5.0408","article-title":"Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma","volume":"97","author":"Sheehan","year":"2002","journal-title":"J Neurosurg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000284360","article-title":"Hyperprolactinemia: different clinical expression in childhood","volume":"73","author":"Saranac","year":"2010","journal-title":"Horm Res Paediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00381-019-04179-z","article-title":"Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study","volume":"35","author":"Locatelli","year":"2019","journal-title":"Childs Nerv Syst."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e14380","DOI":"10.1097\/MD.0000000000014380","article-title":"Clinical characteristics and surgical outcome of prolactinoma in patients under 14 years old","volume":"98","author":"Zhao","year":"2019","journal-title":"Medicine."},{"key":"B21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrendo.2015.112","article-title":"Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism\u2013pathogenesis, diagnosis and treatment","volume":"11","author":"Boehm","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cen.13141","article-title":"ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres","volume":"85","author":"O'Reilly","year":"2016","journal-title":"Clin Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","article-title":"Pharmacologic resistance in prolactinoma patients","volume":"8","author":"Molitch","year":"2005","journal-title":"Pituitary."},{"key":"B25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.rpedm.2014.03.005","article-title":"Assessment of macroprolactinemia by polyethylene glycol precipitation method","volume":"9","author":"Silva","year":"2014","journal-title":"Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1530\/EJE-10-0519","article-title":"Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes","volume":"163","author":"Steele","year":"2010","journal-title":"Eur J Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1365-2265.2003.01748.x","article-title":"Clinical presentation and outcome of pituitary adenomas in teenagers","volume":"58","author":"Cannavo","year":"2003","journal-title":"Clin Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1210\/jc.2014-3670","article-title":"Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients","volume":"100","author":"Salenave","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4274\/jcrpe.v3i2.14","article-title":"Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases","volume":"3","author":"Eren","year":"2011","journal-title":"J Clin Res Pediatr Endocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e5833","DOI":"10.1097\/MD.0000000000005833","article-title":"Surgical treatment for male prolactinoma: A retrospective study of 184 cases","volume":"96","author":"Song","year":"2017","journal-title":"Medicine."},{"key":"B33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1515\/JPEM.2000.13.3.261","article-title":"Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches","volume":"13","author":"Fideleff","year":"2000","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJM199103213241207","article-title":"Diagnosis and management of hormone-secreting pituitary adenomas","volume":"324","author":"Klibanski","year":"1991","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/BF03346388","article-title":"Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients","volume":"31","author":"Vilar","year":"2008","journal-title":"J Endocrinol Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"dos Santos Silva","year":"2011","journal-title":"Obesity."},{"key":"B37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1046\/j.1365-2265.1998.00403.x","article-title":"Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels","volume":"48","author":"Greenman","year":"1998","journal-title":"Clin Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s40618-016-0483-z","article-title":"Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas","volume":"39","author":"Sala","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"B39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000486280","article-title":"Clinical features and response to treatment of prolactinomas in children and adolescents: a retrospective single-centre analysis and review of the literature","volume":"89","author":"Breil","year":"2018","journal-title":"Horm Res Paediatr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.endonu.2012.11.005","article-title":"[Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia]","volume":"60","author":"Halperin Rabinovich","year":"2013","journal-title":"Endocrinol Nutr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/2042098617703647","article-title":"Screening for valve disease in patients with hyperprolactinaemia disorders prescribed cabergoline: a service evaluation and literature review","volume":"8","author":"Gamble","year":"2017","journal-title":"Ther Adv Drug Saf."},{"key":"B43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1365-2265.2007.02905.x","article-title":"Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy","volume":"67","author":"Colao","year":"2007","journal-title":"Clin Endocrinol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/MPH.0b013e31819b71eb","article-title":"Cabergoline resistance in pediatric prolactinomas","volume":"31","author":"Spinks","year":"2009","journal-title":"J Pediatr Hematol Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1677\/erc.0.0090103","article-title":"A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas","volume":"9","author":"Jaffrain-Rea","year":"2002","journal-title":"Endocr Relat Cancer."},{"key":"B46","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00701-005-0498-2","article-title":"Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance","volume":"147","author":"Delgrange","year":"2005","journal-title":"Acta Neurochir."},{"key":"B47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","article-title":"Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis","volume":"15","author":"Roelfsema","year":"2012","journal-title":"Pituitary."},{"key":"B48","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/B978-1-4160-5316-3.00137-4","article-title":"Pituitary tumors: functioning and nonfunctioning","volume-title":"Youmans Neurological Surgery","author":"Jane","year":"2011"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1210\/jcem.79.4.7525627","article-title":"Pituitary adenomas in childhood and adolescence","volume":"79","author":"Kane","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/s1072-7515(01)01101-2","article-title":"The surgical management of pituitary adenomas in a series of 3,093 patients","volume":"193","author":"Jane","year":"2001","journal-title":"J Am Coll Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0038-1625984","article-title":"Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm","volume":"79","author":"Perry","year":"2018","journal-title":"J Neurol Surg B Skull Base."},{"key":"B53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/1658-354X.136424","article-title":"Immediate postoperative complications in transsphenoidal pituitary surgery: a prospective study","volume":"8","author":"Chowdhury","year":"2014","journal-title":"Saudi J Anaesth."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1210\/jc.2003-030979","article-title":"Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis","volume":"89","author":"Colao","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B55","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/erc.0.0080287","article-title":"Pituitary tumors: pathophysiology, clinical manifestations and management","volume":"8","author":"Arafah","year":"2001","journal-title":"Endocr Relat Cancer."},{"key":"B56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1023\/A:1025377816769","article-title":"Medical therapy of macroprolactinomas in males: I. prevalence of hypopituitarism at diagnosis. ii. proportion of cases exhibiting recovery of pituitary function","volume":"5","author":"Sibal","year":"2002","journal-title":"Pituitary."},{"key":"B57","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11102-014-0603-8","article-title":"Effective time window in reducing pituitary adenoma size by gamma knife radiosurgery","volume":"18","author":"Mak","year":"2015","journal-title":"Pituitary."},{"key":"B58","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1227\/NEU.0b013e31821bc44e","article-title":"Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma","volume":"69","author":"Gopalan","year":"2011","journal-title":"Neurosurgery."},{"key":"B59","first-page":"366","article-title":"Gamma knife radiosurgery for pituitary adenomas","volume":"41","author":"Jezkova","year":"2016","journal-title":"Minerva Endocrinol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrendo.2010.4","article-title":"Role of stereotactic radiosurgery in the management of pituitary adenomas","volume":"6","author":"Castinetti","year":"2010","journal-title":"Nat Rev Endocrinol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3171\/jns.2005.102.4.0678","article-title":"Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium","volume":"102","author":"Sheehan","year":"2005","journal-title":"J Neurosurg."},{"key":"B62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2010.5.JNS091635","article-title":"Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes","volume":"114","author":"Sheehan","year":"2011","journal-title":"J Neurosurg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1042-3680(02)00031-1","article-title":"Radiotherapy and stereotactic radiosurgery for pituitary tumors","volume":"14","author":"Petrovich","year":"2003","journal-title":"Neurosurg Clin N Am."},{"key":"B64","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1748-717X-5-109","article-title":"Radiosurgery for pituitary adenomas: evaluation of its efficacy and safety","volume":"5","author":"Castro","year":"2010","journal-title":"Radiat Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrendo.2014.181","article-title":"Genetic mutations in sporadic pituitary adenomas\u2013what to screen for?","volume":"11","author":"Lecoq","year":"2015","journal-title":"Nat Rev Endocrinol."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T04:22:04Z","timestamp":1596514924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":66,"alternative-id":["10.3389\/fendo.2020.00527"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00527","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"article-number":"527"}}